Clinical Trials in Tennessee

Showing 6221-6240 of 20,239 trials

International EXPAND Heart Pivotal Trial

NCT02323321

To evaluate the effectiveness of the OCS™ Heart to recruit, preserve and assess donor hearts that may not meet current standard donor heart acceptance criteria (as identified above) for transplantation to potentially improve donor heart utilization for transplantation

Heart Transplant

TransMedics75 participantsStarted Sep 2015

Los Angeles, California, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +8 more locations

COMPLETEDNA29 miles

Heart EXPAND Continued Access Protocol

NCT03835754

The OCS™ Heart System will be used to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria for transplantation in this continued access protocol.

Heart Transplant

TransMedics75 participantsStarted Apr 2019

Los Angeles, California, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +9 more locations

International EXPAND Heart Pivotal Trial

Heart EXPAND Continued Access Protocol

Find Trials by Condition in Tennessee

CLUSTER Trial for Outbreak Detection and Response

Saypha® VOLUME Lidocaine for Midface Augmentation

Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

The Syn-Sleep Study

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain

Non-Complex Biliary Stones DSC vs ERC

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Polyethylene Wear Particle Analysis of TKA

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function